| Press Release

Mar-23, IDC MarketScape: Worldwide Life Science Sales and Marketing Strategic Consulting Services 2023 Vendor Assessment

Authors:

• Michael Townsend

This IDC study provides an assessment of 12 vendors offering strategic consulting solutions for sales and marketing processes in the life science industry. Digital transformation is occurring at a rapid pace in life science companies, including in the sales and marketing space. Internal and external sources of data are being collected in the cloud, and this information is being leveraged by sales and marketing groups to improve speed, efficiency, and effectiveness in reaching customers, including both healthcare providers and patients. Tools such as artificial intelligence (AI), advanced analytics, and orchestration of multiple tasks and roles utilizing data from multiple sources are accelerating change in 2023 and beyond and helping expand the scope of business processes suitable for outsourcing to qualified vendors.

Mike Townsend, research director for Life Science Commercial Strategies at IDC Health Insights, says, "Life science companies are embracing digital transformation efforts within sales and marketing, which can connect stakeholders such as sales representatives, marketing and medical affairs executives, doctors, patients, and payers using a wide variety of digital technologies, including AI, cloud computing, mobile technology, and social media and analytics, and leveraging a host of internal and external data sources. Highly experienced strategic consulting vendors are offering increasingly sophisticated business models for processes leveraging these technologies while allowing these companies to focus on their core competencies. Life science companies will continue to see improved outcomes, growth, and productivity as they free their organizations to focus on core innovation and business cases, using these offerings to improve outcomes for doctors and patients alike."

| Press Release

Mar-23, What Technologies or Health IT Initiatives Would Healthcare Providers Deploy If They Could Do So at No Cost?

Authors:

• Mutaz Shegewi

This IDC Survey Spotlight presents key findings from IDC's U.S. Healthcare Provider Technology and Connected Health Survey, with a focus on acute/inpatient (e.g., hospitals, regional medical centers, medical centers), ambulatory/outpatient (e.g., outpatient centers, clinics, and physician groups/practices), and post-acute/long-term (e.g., long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, and home health agencies) care settings and technology buyers.

"Some technologies and health IT initiatives far outweigh others when it comes to the affinity U.S. healthcare providers have for and promise of the technology, but these often come at a high cost," says Mutaz Shegewi, research director, IDC Health Insights. "The topmost technologies and initiatives demonstrate that providers want but are challenged by the cost of transforming care, accelerating hybridized (location-agnostic) care delivery, and promoting better clinical collaboration."

| Press Release

Mar-23, Artificial Intelligence Adoption in India’s Public Sector, 2022

Authors:

• Swapnil Shende
• Manoj Vallikkat
• Vinayaka Venkatesh
• Calvin Lau

This IDC Tech Buyer Presentation summarizes the artificial intelligence (AI) technology trends and developments in India’s public sector in the past year and highlights the overall AI spending outlook in 2022 in the government, education, and healthcare sectors. The key drivers behind AI adoption across each vertical with AI trends in the market displays the overall view of each sector. The report also showcases AI-specific guidance for technology buyers across the public sector to leverage AI successfully in their operations and business processes.

| Press Release

Mar-23, IDC Market Glance: Payer, 1Q23

Authors:

• Jeff Rivkin

This IDC Market Glance provides a glance at the current makeup of the payer IT landscape, illustrates the vendor landscape, and depicts the segments and structure of the market.

| Press Release

Mar-23, Key Factors Impacting Life Sciences Tech Strategies and Budgets for 2023 — Risk and Implications

Authors:

• Nimita Limaye

This IDC Survey Spotlight examines key factors impacting life sciences' tech strategies and budgets for 2023. The life science industry has undergone disruptive digital transformation over the past two years, enabling it to sustain and overcome the challenges posed by the COVID-19 pandemic. Technology partners have played a critical role in facilitating this. While two-thirds of the life science industry forecasts a moderate impact of the recession in 2023 lasting for more than a year, its top-most concern is regarding geopolitical turmoil driving changes in its tech providers. In addition:

• Two-thirds of the life science industry and half of the healthcare industry agreed that they wanted to reduce the "run" part of the IT budget to fund new "build" initiatives/projects in 2023.
• 40% of the healthcare industry and a third of the life science industry have changed their IT budget planning cycle to monthly to make adjustments throughout 2023. This is reflective of the need to carefully monitor the evolving landscape and to respond with speed and agility.
• While 45% of the life science industry and 50% of the healthcare industry saw no change in overall IT spending in 2023 as compared with 2022, about 42% of both healthcare and life sciences saw a reduction in specific IT budget items in 2023.
• The business process automation platform provider moved up from the third position in 2022 to the second position in 2023 as the most strategic technology partner for the life science industry, after the primary cloud provider. This is reflective of the need to drive efficiencies and address labor shortages through business automation.
• The primary consulting partner followed as a close third. This speaks to the critical importance of consulting partners, especially in this time of flux. Hence 27% of the industry saw a 5-10% increase in spend in 2023 as compared with 2022 on business consulting services. 20% saw more than a 10% increase in spend on IT consulting services.
• As the life science industry is moving rapidly toward the adoption of hybrid, multicloud strategies, 24% of the life science industry plans to increase its spend on hybrid/cross-cloud services by more than 10% in 2023 as compared with 2022.
• With the increasing focus on deriving intelligent insights from data by leveraging artificial intelligence/machine learning (AI/ML), one sees a 32% increase in spend on AI/ML in 2023 by the life science industry.
• Approximately 10% of the life science industry plans on a more than 10% reduction in general-purpose compute instances and special-purpose compute platforms; general-purpose storage systems, enterprise network equipment, PaaS data services, and application platforms; and devices in 2023.
• Application modernization and cloud migration services remain a priority with 64% increasing spend on the same by up to 10% in 2023.

| Press Release

Mar-23, Is the Metaverse Virtually a Reality for Life Science R&D?

Authors:

• Nimita Limaye

This IDC Perspective reviews the significant potential of the metaverse and how it could transform the life science industry. It covers key use cases, analyzes the vendor landscape, reviews implementation challenges, and provides guidance to the technology buyer.

"As clinical trials go remote and the ask for the personal touch heightens, the metaverse will deepen patient engagement, shape patient behaviors, and transform patient and provider training. There will be increasing adoption of virtual reality in digital therapeutics to treat mental health disorders. Immersiveness will serve as a key differentiator, multiple use cases and multiple technologies will converge over time and will reshape existing models and patient experiences. On the long run, the metaverse will transform the way decentralized clinical trials are implemented. The reality is that the application of the metaverse in pharma is no more virtual," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC Health Insights.

| Press Release

Mar-23, Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment

Authors:

• Nimita Limaye

This IDC Perspective reviews the paradigm shift of the life sciences industry from conventional models to patient recruitment strategies that focus on using RWD, leveraging SDoH to drive diversity and equity in clinical trials, and the significant potential of digital biomarkers in driving patient recruitment. It reviews the factors that need to be taken into consideration when using RWD and the key players in this space and provides guidance to technology buyers as well.

"The use of RWD to refine eligibility criteria and optimize patient recruitment is becoming the new normal. Leveraging SDoH to drive diversity in clinical trials, and the use of digital biomarkers, especially for recruiting patients with neurological diseases, are the bellwether of a coming revolution in clinical trial recruitment strategy," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights.

| Press Release

Mar-23, IDC Market Glance: Value-Based Healthcare Analytics, 1Q23

Authors:

• Jennifer Eaton

This IDC Market Glance provides an overview of key healthcare analytic markets for 2023.

"With the evolution of value-based healthcare initiatives and goals, organizations are relying on analytic advancements to offset challenges and spur innovation aimed at better healthcare outcomes for all. Healthcare as a whole continues an uphill climb toward lower cost and higher quality care. Recent mergers and acquisitions are creating new synergies and collaboration that not only changes the healthcare landscape but challenges all members of the ecosystem to reimagine how analytics, AI/ML, and other technologies can better support scalable and sustainable change." — Jennifer Eaton, research director, Value-Based Healthcare Digital Strategies at IDC

| Press Release

Feb-23, Worldwide Medical Devices Key IT Deals and Initiatives Update, 4Q22

Authors:

• Nino Giguashvili

This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the worldwide medical devices market in 4Q22. This is the second in the new quarterly series of reports that IDC Health Insights launched following the expansion of its in-depth research coverage of the global medical devices industry.

"The medical devices industry is facing significant uncertainty due to ever-growing demand from the healthcare sector, economic and geopolitical pressures, changing market access models, and increasingly complex consumer demands. Medical devices companies are under mounting pressure to accelerate technology investments to address current challenges, adapt to the rapidly changing market environment, and explore new avenues of innovation to create greater value for healthcare providers and consumers." — Research Manager Nino Giguashvili, IDC Health Insights

| Press Release

Feb-23, Government Survey- Asia Pacific- 2022- Spot Analysis-1

Authors:

• Jezamin Abdul Razak
• Manoj Vallikkat
• Calvin Lau

This IDC report provides an analysis of the public sector segment as part of IDC’s 2022 Public Sector Asia/Pacific Survey, which was conducted in June 2022. The respondent profiles include IT managers and higher. The survey covers innovative solutions, such as the future technologies governments plan to invest in, hybrid work strategies that organizations aim to implement in the future, driving forces in data governance, data sharing awareness, and future innovation in health and education.

"Governments in the region have become more accustomed to technological advances and will strive to exploit them to their fullest potential. The adoption of new technologies is critical to advance toward more streamlined operations and enable organizations in the region to make the best use of the possibilities offered by emerging technologies," says Jezamin Abdul Razak, head of government insights, IDC ASEAN Region.

| Press Release

Feb-23, IDC PeerScape: Healthcare Data Security Management Practices in China

Authors:

• Leon Xiao
• James Wang
• Erin Lin

This IDC PeerScape discusses the challenges faced by institutions, such as the National Health Commission of the People's Republic of China, National HealthcareSecurity Administration, and hospitals in the construction of healthcare data security, and presents practical cases and recommendations to provide reference for the data security of various units.

Leon Xiao, senior research manager at IDC China says, "With the gradually increasing value of healthcare data, various healthcare institutions are embarking on the construction of healthcare data platforms. Data security is an important prerequisite for data application and opening. However, data security in the healthcare industry is generally in the early exploration stage, and the preventive measures are not sound. With the continuous improvement of policies and regulations and the industry's increased attention to data security, demand for data security in China's healthcare industry is ushering in growth."

| Press Release

Feb-23, By End of 2026, 55% of Healthcare Organizations in Asia/Pacific* Will Have Data Governance Frameworks in Place to Prioritize the Ethical and Explainable Use of AI in Healthcare, IDC Predicts

IDC Asia/Pacific Releases Top Healthcare Predictions for 2023 and Beyond

| Press Release

Feb-23, Market Perspective: Healthtech DNBs in India and Opportunities for IT Providers

Authors:

• Sairam Balasubramani
• Seng Keong Low
• Daniel-Zoe Jimenez

The COVID-19 pandemic accelerated the development of healthtech by opening new opportunities and scope for growth. This report presents current opportunities for healthtech digital-native businesses (DNBs) and opportunities for technology vendors to help them reach their goal toward customer acquisition, path to resiliency, and public offering.

"Healthtech DNBs are growing rapidly, and partnerships are a win-win for DNBs and technology vendors in terms of having faster go-to-market (GTM) strategies and tapping into underserved markets. As the growth of DNBs progresses, the need for complex technology rises, leading to outsourcing of services from technology vendors," says Sairam Balasubramani, senior market analyst, IDC India.

| Press Release

Feb-23, SCAPA Report Series: Urban Planning and Land use

Authors:

• Jezamin Abdul Razak
• Manoj Vallikkat
• Ravikant Sharma

Selected urban planning initiatives from Asia/Pacific nations are covered in this IDC report. When it comes to urban planning for the future, it is vital to construct robust downtown districts, mixed-use zones, human-powered and multimodal transit networks, and green spaces. The United Nations predicts that approximately 70% of the world's population will live in cities by the year 2050. Cloud computing, the Internet of Things (IoT), and virtual reality are some examples of cutting-edge technologies that could be more fully integrated into urban design.

"Incorporating future technologies into urban planning will make it possible to achieve a better quality of life, better environment, more sustainable infrastructure, more aesthetically pleasing cities, and a more prosperous nation,"says Jezamin Abdul Razak, senior research manager, IDC

| Press Release

Feb-23, CVS Health to Acquire Oak Street Health to Strengthen Value-Based Healthcare Offerings

Authors:

• Jennifer Eaton
• Mutaz Shegewi

CVS Health announced its intent to acquire Oak Street Health (or Oak Street) for $10.6 billion in an all-cash transaction at $39 per share. This latest purchase comes on the heels of an announcement that CVS Health would spend approximately $8 billion to buy Signify Health, a home health and technology company. Now with Oak Street Health coming into the fold, CVS Health’s President and CEO Karen S. Lynch states in the acquisition press release, "enhancing our value-based offerings is core to our strategy as we continue to redefine how people access and experience care that is more affordable, convenient, and connected."

| Press Release

Feb-23, IDC PlanScape: Measuring and Scaling the ROI on Decentralized Clinical Trials for the Life Science Industry

Authors:

• Nimita Limaye

This IDC PlanScape addresses the growing importance of decentralized clinical trials (DCTs), provides insights on the benefits and challenges associated with DCTs, identifies the key stakeholders involved, and provides guidance to the life science industry on how to choose the right partners and which are the critical key performance indicators (KPIs) that should be monitored to optimize the return on investment.

"Decentralized clinical trials are reshaping the life science industry. As organizations are rapidly attempting to transition from a 'pilotitis' mode to an enterprisewide implementation strategy, they need to take cognizance of the importance of defining key performance indicators, which will serve as measures of success through their DCT journey. The life science industry needs to develop a 'DCT Organizational Maturity Score' for DCT implementation, akin to a capability maturity model (CMM), which will help organizations to benchmark their performance, against themselves and against the industry," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC Health Insights.

| Press Release

Feb-23, Retail Pharmacies — Transforming the Clinical Trial Landscape and Fueling Clinical Research as a Care Option (CRAACO)

Authors:

• Nimita Limaye

This IDC Perspective analyzes the increasing involvement of retail pharmacies in clinical trials, especially in the United States, and how this is gradually making clinical research as a care option (CRAACO) a reality. It analyzes the various strategies being implemented by the retail pharmacies and provides guidance to the tech buyer on partnering decisions.

"In the past two years, retail pharmacies in the United States have rapidly entered the clinical trial arena, offering increased access to a diverse patient population, building out real-world data offerings, partnering with decentralized clinical trial vendors, and strengthening their primary care offerings. The integration of clinical trials within the patient's care continuum is important to increase access and improve outcomes. The global adoption of this model needs to follow, and this will happen over time. The race has just begun, and we have a long way to go," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights.

| Press Release

Jan-23, How Are Digital Transformation Investments Impacting Healthcare Business Priorities?

Authors:

• Jennifer Eaton

This IDC Survey Spotlight derives data from IDC's Future Enterprise Resiliency and Spending Survey (FERS), Wave 11, with a focus on healthcare organizations' digital healthcare strategies.

"Despite significant economic, political, and geographic challenges, healthcare organizations are keeping their eye on the ball when it comes to digital transformation's top goal: customer satisfaction," says Jennifer Eaton, research director, IDC Health Insights.

| Press Release

Jan-23, The Pulse of IT in the European Healthcare Market: Key Deals and Initiatives, October-December 2022

Authors:

• Federico Mayr

This IDC Perspective looks at key developments and news in the European healthcare market in 4Q22.

"In the last quarter of 2022, key IT deals and initiatives continued to focus on enabling virtual care provision to improve access to care in a context of rising costs and workforce shortages. However, effort is required from all stakeholders in the healthcare ecosystem to assure quality, safety, and continuity of care," said Federico Mayr, research analyst, IDC Health Insights Europe.

| Press Release

Jan-23, Deep Dive: Artificial Intelligence for Payer Use Cases

Authors:

• Jeff Rivkin

This IDC Perspective takes a deep dive into artificial intelligence for payer use cases. In the past decade, health insurance companies have been looking to artificial intelligence (AI) and machine learning (ML) to identify at-risk individuals and reduce rising costs in the healthcare sphere.

It's important to note that a majority of the price consumers pay when enrolling in health insurance goes into risk prediction and risk management. By using AI to create a system that can create more accurate risk models and predict which individuals need specific types of care, health insurance providers can spend more money on their beneficiaries and less on those processes. Platforms that can take in, study, and learn from data; refine judgments; and generate intelligent insight can also greatly reduce the need for expensive human data analysts.

When AI is injected into ways of working across the payer workforce, employees can be liberated from more tactical and mundane work. They can be redirected to more strategic tasks, tapping into previously unavailable internal and external data for more insight-driven ways of working. This can translate into new products and services that improve service and member health while supporting new growth strategies for the business.

"The use of AI in health insurance is quickly driving improvements and changing the relationship between payers, providers, and members. It helps enhance and streamline the member/patient experience and make internal operations easier," says Jeff Rivkin, research director, Payer IT Strategies at IDC Health Insights. "While there is still plenty of room to enlarge scope of this technology, it is clear that AI has a foothold in payers."

| Press Release

Jan-23, Payers' Guide to the Future of Trust

Authors:

• Jeff Rivkin

This IDC Perspective explains why trust is the most important currency in the digital era as well as a cornerstone of digital health. To build trust, payers should implement AI-powered digital experiences that improve listening capabilities, support first-time resolution of member issues, and improve the consistency and clarity of the information provided. If there is no member trust, then engagement, loyalty, and future growth hang in the balance.

"Member trust is not a 'soft' issue for payers. It is a must-have foundation that brings strategic value to the business in the digital economy. Trust is a key driver of member and provider retention and is the lifeblood of the payer business model," says Jeff Rivkin, research director for IDC Health Insights.

| Press Release

Jan-23, IDC FutureScape: Worldwide Healthcare Industry 2023 Predictions — Asia/Pacific (Excluding Japan) Implications

Authors:

• Manoj Vallikkat
• Calvin Lau
• Mutaz Shegewi
• Lynne Dunbrack

This IDC study presents the top 10 predictions for the healthcare industry in Asia/Pacific (excluding Japan) (APEJ), for the next five years. In the process of aligning with the care needs, healthcare organizations are set to have increased priority on establishing "care anywhere" programs, leveraging clinical data, exploring seamless connectivity, and automating care processes, along with strong anchoring on trust, compliance, and explainability.

IDC's healthcare industry top 10 predictions provide guidance to healthcare leaders on preparing and responding to the major storms of disruptions, big tech flips, and the after-effects of the pandemic.

"The healthcare delivery system in Asia/Pacific is undergoing a transition toward patient-centricity. This transition is strongly facilitated by the evolution of the digital front door, healthtech ecosystem, and enhanced focus on data, redefining care further into care anywhere, predictive care, and personalized care. Although there is focus on the use cases that leverage emerging technologies, moving forward, the industry will witness increased involvement of line-of-business (LOB) heads along with IT leaders, as part of the ecosystem," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Healthcare Insights.

| Press Release

Jan-23, IDC FutureScape: Worldwide Healthcare Industry 2023 Predictions — APEJ Implications: Positioning for Success — Opportunities for Tech Sales and Marketing Leaders

Authors:

• Manoj Vallikkat
• Calvin Lau

This IDC Presentation is an accompanying piece to the main IDC FutureScape 2023 report titled Worldwide Healthcare Industry 2023 Predictions — Asia/Pacific (Excluding Japan) Implications. This report provides specific recommendations for two tech vendor personas, tech sales leaders and tech marketing leaders, aligning with the set of predictions.

"The healthcare industry in Asia/Pacific is passing through an exciting phase. A phase that extensively leverages emerging technologies, a phase that prioritizes capturing and leveraging clinical data, and a phase that focuses on enhancing both patient and clinician experience. On one side of this phase, there is pressure to invest in innovative technologies to cater to patient-centric care demands; on the other is the need for acceptability, adaptability, and scalability of any given solution. Moving forward, tech vendors will have to cater to the latter part and have increased focus on use cases, explainability, and compliance while being a key cohesive partner in the healthtech ecosystem," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Healthcare Insights.

| Press Release

Jan-23, Industry Personas Handbook: Worldwide Healthcare 2022/2023

Authors:

• Federico Mayr
• Silvia Piai
• Manoj Vallikkat
• Lynne Dunbrack

This IDC Presentation examines IDC's Worldwide Healthcare Provider Personas Handbook, which is designed to provide technology vendors a better understanding of their buyer personas. It aims to answer the following questions:

Who are the key personas I need to address with my:

• Offering (products and services)
• Marketing messages
• Sales campaign
• Sales activity

What are their strategic priorities and their day-to-day activities?

What are their major pains and challenges?

What are their KPIs?

This IDC Presentation focuses on the C-suite level and provides an overview of the key executives in healthcare provider organizations. The strategic priorities, pain points, and KPIs described for each persona are intended to support the early stages of the sales funnel such as in the stages of awareness creation, interest, and consideration. It will not focus on how to approach procurement departments once decisions for purchase have been made.

"This Industry Personas Handbook provides meaningful buyer archetypes that vendors can use to assess their healthcare go-to-market strategies and messaging. This handbook will help them driving greater interest and engagement from a broader group of healthcare decision makers and influencers," said Silvia Piai, research director, IDC Health Insights. "The personas in this handbook hold the authority to make purchasing decisions that influence the achievement of the strategic goals of a healthcare provider," said Federico Mayr, research analyst, IDC Health Insights.

| Press Release

Dec-22, Today, Meet Tomorrow: How Google Cloud Empowers Businesses to Be Future-Ready

Authors:

• Manoj Vallikkat
• Sakshi Grover
• Swapnil Shende

This IDC Market Note discusses the Google Cloud India Analyst Summit 2022, held in Bengaluru on October 12. The summit extends an opportunity to hear from both global and Indian leadership of Google Cloud along with technical experts on wider areas, such as how Google helps transform various businesses, ministries, and the developer community. The event concluded with an exclusive analyst session that extended an opportunity to hear from Google Cloud's customers and partners. "Successful transformation for business requires a unified approach to link multiple business strategies to transformation execution strategies. To achieve the desired business outcomes, a secure and operationally efficient cloud ecosystem becomes an obvious choice. Google Cloud is creating success stories and expanding its customer and partner ecosystem across multiple industries and Google Cloud Platform, including its Open Cloud, Data Cloud, Trusted Cloud, and Collaboration Cloud," says Swapnil Shende, associate research manager for Artificial Intelligence, IDC India.

| Press Release

Dec-22, IDC Market Glance: Healthcare Provider Clinical IT Solutions, 4Q22

Authors:

• Mutaz Shegewi

This IDC Market Glance highlights the healthcare provider clinical IT solutions for 4Q22. "Healthcare providers continue to navigate the aftereffects of the pandemic combined with the impact of inflationary pressures, supply chain constraints, labor and skills shortages, the consequences of the Russia-Ukraine War, escalating cybersecurity risks, shifting care models, and the ongoing need to strive for service excellence while addressing broader systemic challenges," says Mutaz Shegewi, research director, IDC Health Insights. "The disruptive nature of the market continues to transform healthcare providers that are looking for solutions that can support interoperable data through the HL7 FHIR standard, typically in the form of "as a service" offerings that can offset the cost of developing and acquiring new IT skills and infrastructure investments, and despite having higher fees."

| Press Release

Dec-22, The European Health Data Space: Opportunities for European Healthcare and Life Sciences

Authors:

• Silvia Piai

This IDC Tech Buyer Presentation provides an overview of the European Health Data Space (EHDS) initiative. It examines how the EHDS can create an ecosystem comprising rules, common standards/practices, infrastructures, and a governance framework for primary and (more importantly) secondary use of health information in Europe. It analyzes opportunities and key challenges that the EHDS brings for European healthcare and life sciences organizations.

This presentation was delivered on November 3, 2022, during the Common European Data Spaces and the Data Economy webinar. This webinar is part of activities for the European Data Market study 2021-2023, a project led by IDC in cooperation with the Lisbon Council.

The European Data Market is a European Commission–funded study that aims to define, assess, and measure the European data economy, with an eye toward supporting the data value chain policy of the European Commission. The program focuses on developing an innovative data ecosystem of stakeholders that drives the growth of this innovative market in Europe. The main results will feed into the annual reviews of the Digital Agenda Scoreboard.

| Press Release

Dec-22, Worldwide Medical Devices Key IT Deals and Initiatives Update, 3Q22

Authors:

• Nino Giguashvili
• Federico Mayr
• Silvia Piai

This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the worldwide medical devices market in 3Q22. This is the first in the new quarterly series of reports that IDC Health Insights has launched following the expansion of its in-depth research coverage of the worldwide medical devices market.

"In the evolving industry environment, medical device market players must closely follow the global industry trends and larger ecosystem developments to capitalize on favorable opportunities and strengthen their resilience to survive and thrive in the next normal. We hope these quarterly document series will benefit all stakeholders in the extended medical devices ecosystem," said Nino Giguashvili, research manager, IDC Health Insights.

| Press Release

Dec-22, ESG as a Key Driver for Medical Devices Industry Modernization

Authors:

• Nino Giguashvili

This IDC Survey Spotlight examines the actions and practices medical devices companies are adopting to drive sustainability and deliver on the new global standards for environmental, social, and governance (ESG) goals.

The document offers insights into the impact of new global sustainability standards on the business agendas and technology investment priorities of medical devices organizations. The analysis is based on the medical devices sample of IDC's European Healthcare and Life Sciences Insights Survey, 2022.

| Press Release

Dec-22, IDC Market Glance: Healthcare Provider Operational IT Solutions, 4Q22

Authors:

• Mutaz Shegewi

This IDC Market Glance highlights the healthcare provider operational IT solutions for 4Q22.

"Healthcare providers continue to navigate the aftereffects of the pandemic combined with the impact of inflationary pressures, supply chain constraints, labor and skills shortages, the consequences of the Russia-Ukraine War, escalating cybersecurity risks, shifting care models, and the ongoing need to strive for service excellence while addressing broader, systemic challenges," says Mutaz Shegewi, research director, IDC Health Insights. "The disruptive nature of the market continues to transform healthcare providers that are looking for solutions that can support interoperable data through the HL7 FHIR standard, typically in the form of "as a service" offerings that can offset the cost of developing and acquiring new IT skills and infrastructure investments, and despite having higher fees."

| Press Release

Dec-22, Medidata NEXT 2022: Solving the Impossible

Authors:

• Nimita Limaye
• Michael Townsend

This IDC Perspective reviews the industry analyst event recently hosted by Medidata (a Dassault Systemes [DS] company) from November 15 to 16, 2022, in New York. It was addressed by Life Sciences and Healthcare Sector Board Chairman, DS, Tarek Sherif; co-CEOs of Medidata (Rama Kondru and Sastry Chilukuri); and the CEO of Patient Cloud (Anthony Costello), as well as Medidata's leadership, partners, and customers who outlined the new offerings and the strategic road map for Medidata in life sciences.

"As technology adoption continues to scale rapidly in the life sciences industry, the industry and technology providers continue to innovate; pharmas and biotechs are looking for solutions that will drive quality and compliance, accelerate time to market, and weave in both a site-centric and a patient-centric focus. Technology solutions that power decentralized clinical trials, that drive diversity and equity, that improve access, that integrate a risk-based quality management strategy, and that drive interoperability will serve as differentiators and define the pace of innovation for the life sciences industry," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC Health Insights.

"Consolidated clinical trial results, augmented by real-world data and patient and provider insights, can help construct rich patient journey experiences that help life sciences companies and healthcare providers find patients who can benefit from innovative therapies and result in improved health outcomes and better knowledge sharing between researchers, medical affairs experts, providers, and patients," says Michael Townsend, research director, Life Sciences Commercial Strategies at IDC Health Insights.

| Press Release

Dec-22, U.S. Consumer and Provider Adoption Trends: Remote Patient Monitoring

Authors:

• Lynne Dunbrack

This IDC Tech Buyer Presentation analyzes data from IDC's January 2022 U.S. Healthcare Provider Technology and Connected Health Survey and IDC's January 2022 U.S. Consumer Healthcare Survey, with a focus on how health provider organizations are deploying remote health monitoring and wearable devices and consumers' adoption of them, respectively. This study also examines consumer satisfaction levels with using these devices.

"Healthcare organizations are deploying remote health monitoring and wearable devices to enable care anywhere and hospital-at-home initiatives," states Lynne A. Dunbrack, group vice president, IDC Health Insights. "As healthcare organizations embark on their remote health monitoring strategy, they need to understand how their clinicians and patients want to use this patient-generated information to ensure all constituents' expectations are met."

| Press Release

Dec-22, Consumer and Provider Adoption Trends: Virtual Care

Authors:

• Lynne Dunbrack

This IDC Tech Buyer Presentation analyzes data from the U.S. Healthcare Provider Technology and Connected Health Survey, January 2022, and U.S. Consumer Healthcare Survey, January 2022, with a focus on how health provider organizations are deploying technology to support virtual visits and consumers adoption of them, respectively. This document also examines consumer satisfaction levels with the virtual visit experience.

"The lines between in-person care and digital-first care is blurring as consumers seek more convenient access to care," states Lynne A. Dunbrack, group vice president, IDC Health Insights. "As healthcare organizations embark on expanding their telehealth/telemedicine strategy to include virtual care, they should identify people, technology, clinical workflows, and business processes to reduce risk, promote adoption, and realize the benefits of virtual care."

| Press Release

Dec-22, PwC Live 2022: Delivering the New Equation for the Public Sector

Authors:

• Ruthbea Yesner
• Nimita Limaye
• Lynne Dunbrack

This IDC Market Note reviews the industry analyst event recently hosted by PwC and summarizes PwC's plans to drive large-scale transformation, business process reengineering, change management, and compliance.

"Digital transformation can transition organizations from being 'fit for purpose' to being 'fit for the future.' Agile innovation and workforce transformation are needed to weather the storms of disruption that are rocking the world today," states Lynne A. Dunbrack, group vice president, Public Sector at IDC.

| Press Release

Dec-22, IDC MarketScape: U.S. RCM Product Solutions 2022-2023 Vendor Assessment

Authors:

• Mutaz Shegewi

This IDC study assesses revenue cycle management (RCM) product solutions currently available in the U.S. market. This study aims to provide technology buyers with insight into the strategies, capabilities, and criteria that healthcare organizations should consider when selecting an RCM product solution.

"Many providers do not have a clear idea of what revenue cycle product solutions are out there, better yet the value and benefits these can deliver to their organizations," says Mutaz Shegewi, research director, Worldwide Provider IT Transformation Strategies at IDC. "This is a new day and age for healthcare where the lines between providers and payers are blurrier than ever. RCM product solutions play an important role in ensuring that providers can better manage their revenue cycles from end to end and introduce next-generational capabilities that translate the technology investment into value not only through an impact on the bottom line but through better experiences for staff and patients as well."

| Press Release

Dec-22, IDC MarketScape: U.S. RCM Service Solutions 2022-2023 Vendor Assessment

Authors:

• Mutaz Shegewi

This IDC MarketScape assesses revenue cycle management (RCM) service solutions currently available in the U.S. market. This study aims to provide technology buyers with insight into the strategies, capabilities, and criteria healthcare organizations should consider when selecting an RCM service solution.

"Many providers do not have a clear idea of what revenue cycle service solutions are out there, better yet the value and benefits these can deliver to their organizations," says Mutaz Shegewi, research director, Worldwide Provider IT Transformation Strategies at IDC. "This is a new day and age for healthcare where the lines between providers and payers are blurrier than ever. RCM service solutions play an important role in ensuring that providers can better manage their revenue cycles from end to end and introduce next-generational capabilities that translate the technology investment into value not only through an impact on their bottom line but through better experiences for staff and patients as well."

| Press Release

Dec-22, Life Science Revenue Management in the Cloud, 2022

Authors:

• Michael Townsend

This IDC Survey Spotlight analyzes trends and deployment plans based on results from IDC's Industry CloudPath Survey (April 2022) and IDC's Life Sciences DX Survey (March 2022). Life science companies are increasingly deploying their revenue management solutions in the cloud.

| Press Release

Dec-22, Deployment of AI in Life Science Commercial Use Cases, 2022

Authors:

• Michael Townsend

This IDC Survey Spotlight analyzes deployment of AI in selected life science commercial applications and use cases, based on responses in IDC's Industry AI Path Survey, September 2022.

| Press Release

Dec-22, The Value of a Modern Data Infrastructure to Accelerate Clinical Diagnosis: The Case of Munich Leukemia Laboratory

Authors:

• Adriana Allocato
• Silvia Piai

This IDC Perspective illustrates the case of Munich Leukemia Laboratory (MLL), which adopted a cloud-first strategy to address its increasing compute and storage needs as well as support its business innovation plans. The case analyzes key factors that helped MLL to successfully analyze and process next-generation sequencing (NGS) and other diagnostic data in the cloud.

"As European healthcare providers pursue data-driven care delivery models, cloud technology investments are critical to support data integration, data sharing, and the use of advanced analytics and AI. By adopting cloud-first strategies, healthcare organizations reimage their IT enterprise architecture to streamline operations as well as improve their productivity and quality of care," said Adriana Allocato, research manager, IDC Health Insights Europe.

"The opportunities offered by cloud have been a catalyst of greater collaboration between clinical and IT professionals to streamline processes and develop new services, bringing innovation in the business model of MLL as well," said Silvia Piai, research director, IDC Health Insights Europe.

| Press Release

Dec-22, IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment

Authors:

• Nimita Limaye

This IDC study focuses on a combination of PV technology solutions and consulting services. This IDC MarketScape provides a qualitative and quantitative assessment based on criteria that should be important to life science companies when considering the selection of a strategic PV solution provider to help provide guidance for strategic, operational, and tactical transformation issues within the PV space, as well as technology platforms, and build capabilities. This is the second time that an IDC MarketScape assessment of PV solutions for life science R&D has been performed.

Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology at IDC, noted, "Pharmacovigilance has gained significant importance and a more visible public profile post the COVID-19 pandemic. The surge in the volume of cases, the need to accelerate innovation while ensuring patient safety, and the need to address the distrust that the pharma industry experienced during the pandemic, all call for a focused effort toward implementing a forward-looking PV strategy and adopting technology solutions that leverage cognitive automation, build compliance, drive efficiency, ensure patient safety, and build transparency and trust."

| Press Release

Nov-22, Payer Payment Integrity Becoming More Predictive, Integrated

Authors:

• Jeff Rivkin

This IDC Perspective highlights how payer payment integrity is becoming more predictive and integrated. Payers and providers are working diligently to make accurate payments to providers in a single pass with precise audit trails and embedded business intelligence to facilitate better relationships with providers, reduce waste, and improve financial performance.

"Payment integrity suites that provide a single solution for both pricing and editing, handling all lines of business, connecting all core claims platforms, handling both fee-for-service and fee-for-value contracts will become the enterprise standard for payers over the next three years. Payers that can overcome organizational fragmentation with common, integrated, transparent technology will benefit greatly," says Jeff Rivkin, research director for Payer IT Strategies for IDC Health Insights.

| Press Release

Nov-22, IDC MarketScape: U.S. Enterprise Medical Imaging 2022-2023 Vendor Assessment

Authors:

• Mutaz Shegewi

This IDC study assesses enterprise medical imaging solutions currently available in the U.S. market. This study aims to provide technology buyers with insight into the strategies, capabilities, and criteria healthcare organizations should consider when selecting an enterprise medical imaging solution.

"The journey for any healthcare organization to realize an optimized and converged medical imaging environment takes time, effort, and resources. Once completed, the organization will enter a new era, where the many investments and sacrifices made on enterprise medical imaging will pay off," says Mutaz Shegewi, research director, Worldwide Provider IT Transformation Strategies at IDC.

| Press Release

Nov-22, IDC FutureScape: Worldwide Healthcare Industry 2023 Predictions — Canada Implications

Authors:

• Mark Schrutt
• Jason Bremner

This IDC Tech Buyer Presentation discusses the Canadian regionalization of IDC FutureScape: Worldwide Healthcare Industry 2023 Predictions (IDC #US48587222, October 2022). It provides a detailed perspective on the forces shaping business and the Canadian healthcare market over the next several years. Each prediction is presented based on the timeline projection, complexity assessment, and organizational impact on the "mainstream" market.

Technological advances are moving faster than the Canadian healthcare system's ability to use them. Canadian healthcare organizations are struggling with issues centered on the workforce, capacity, and wait times. There is also an overarching need for health equity. Over the past decade, and particularly since COVID-19, the system has begun to show signs of breaking down," says Mark Schrutt, strategic advisor, Public Sector and Innovation research, IDC Canada.

The technologies highlighted in this presentation can be part of the solution:

• Integrated care and access to services, including those delivered remotely
• Hybrid work environment, although there is a need to complement care with local and at-home support
• AI, robotics, and data-driven command centres

| Press Release

Nov-22, IDC Market Glance: Healthcare Ecosystem, 4Q22

Authors:

• Lynne Dunbrack
• Jennifer Eaton
• Jeff Rivkin
• Mutaz Shegewi

This IDC Market Glance provides a landscape view of the key technology markets for 2022. Vendors in each subcategory may evolve and change each year to create a representative collection.

"2022 brought a flurry of mergers and acquisitions (e.g., Oracle and Cerner, UHG/OptumInsight and Change Healthcare) that will impact the long-term trajectory of healthcare technology goals such as increased interoperability, efficiency, individualized healthcare experiences, and greater access to quality care. Building on residual challenges related to COVID-19 and driving the need for technology to offset these challenges, healthcare is also facing pressures related to inflation and labor and skill shortages that will inform technology investments." — Lynne A. Dunbrack, group vice president, IDC Health Insights

| Press Release

Nov-22, IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment

Authors:

• Nimita Limaye

This IDC study focuses on a combination of RBM technology and consulting solutions. This IDC MarketScape provides a qualitative and quantitative assessment based on criteria that should be important to life science companies when considering the selection of a strategic RBM solution provider to help provide guidance for strategic, operational, and tactical transformation issues within the RBM-RBQM space, as well as technology platforms, and build capabilities. This is the first time that an IDC MarketScape assessment of RBM solutions for life science R&D has been performed.

Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology at IDC, noted, "The differentiator for great enterprises is not the amount of data that they have but the intelligence that they extract from it to minimize study risk, enhance data quality, and drive patient safety. The future of intelligence for clinical trials encompasses effectively leveraging an RBQM strategy, deeply embedding a QbD approach within the organization's DNA, building a quality-centric culture, and optimizing the use of technology solutions to develop an agile, predictive, prescriptive, and a proactive strategy to managing risks."

| Press Release

Nov-22, Shaping India's Public Sector: How AWS Supports Leveraging Cloud and Emerging Technologies

Authors:

• Manoj Vallikkat
• Rajiv Ranjan
• Sakshi Grover
• Sharath Srinivasamurthy
• Swapnil Shende

This IDC Market Note reviews the Amazon Web Services (AWS) Summit New Delhi held in September 2022 and covers various use cases highlighted during the event. It also covers the public sector's view of AWS, the company's efforts in reducing the total cost of ownership, key government initiatives in India, and the role played by AWS in achieving the objectives of public sector enterprises with supportive use cases.

| Press Release

Nov-22, Diverse Business Priorities Spur a Projected Increase in Healthcare AI Investments

Authors:

• Jennifer Eaton

This IDC Survey presents selected results of healthcare organizations' participation in IDC's May 2022 Industry AI Path Survey. With increased projected AI investment and competing business priorities, healthcare organizations are forging ahead with reliance on AI for better quality of services, improved customer experience, and increased competitiveness in the market. Organizations with a strong enterprisewide AI strategy in place reported the highest levels of business driver improvement thus emphasizing the importance of a cohesive and well-aligned strategy as the foundation for AI success.

"This survey data provides insights into healthcare AI strategies, drivers, challenges, and investment trends. Understanding the complexities of both provider and payer challenges in today's ecosystem aids technology suppliers in developing tools and services that mitigate risk, optimize impact, and build trust and loyalty between vendor and client," says Jennifer Eaton, research director, IDC Health Insights.

| Press Release

Nov-22, Smart Cities Asia/Pacific Awards Report Series: Transportation — Transport Infrastructure

Authors:

• Jezamin Abdul Razak
• Manoj Vallikkat
• Ravikant Sharma

This IDC report covers selected projects from Asia/Pacific countries that incorporate the use of technology for transportation infrastructure. There is a growing demand for effective transportation options for both people and commodities as a direct result of the expansion and increased population of urban areas. To meet the climate change goals, governments are rushing to make transportation more environmentally friendly. Nevertheless, the infrastructures for transportation would need to be resilient and comfortable. Increasing the reliability of the country's transportation network in the face of natural disasters is a top priority for many governments. Digitization and widespread use of technology are important ways to reach this goal.

"Data analytics and artificial intelligence (AI) enable governments to predict climate disasters, manage assets, and lead response measures. With new technologies, transportation can be more citizen-centric. The improvement of transportation's compatibility with other aspects of societal life will be a primary goal of future technological development," says Jezamin Abdul Razak, head of government, Insight, IDC ASEAN.

| Press Release

Nov-22, IDC Market Glance: Industry Cloud in Asia/Pacific (Excluding Japan), 4Q22

Authors:

• Daphne Chung
• Stephanie Krishnan
• Clay Miller
• Manoj Vallikkat
• Ayush Narain

This IDC Market Glance provides a glimpse at the current makeup of the industry cloud market landscape in Asia/Pacific (excluding Japan) (APEJ). Although this is not an exhaustive list of the players in the market, it provides a view pf the major players in the region and includes significant local players wherever applicable in various segments of the market.

| Press Release

Nov-22, Worldwide Medical Devices, 2022

Authors:

• Nino Giguashvili
• Federico Mayr
• Silvia Piai

This IDC Market Analysis Perspective examines the worldwide medical devices market. It delivers a concise view of the current state of the market and its digital transformation trends, provides an overview of the ecosystem of players, and offers insights into the impact of future trends. Medical device organizations' IT executives and their IT vendors can use this information to understand key industry impacts to seize market opportunities.

"The value chains of medical devices companies are rapidly changing to support the evolution toward integrated and personalized healthcare models and the adoption of innovative and complex approaches such as precision medicine. At the same time, medical devices companies will need to help healthcare organizations to lower costs and become more resilient. This requires creating value beyond the device that can be achieved only by adopting new, digitally enabled business and operating models," said Silvia Piai, research director, IDC Health Insights. "Forward-looking technology companies will leverage their digital strategies also to adapt to the fast-evolving regulatory landscape worldwide, which includes new ESG, quality, and safety requirements," said Nino Giguashvili, research manager, IDC Health Insights. "Moreover, looking beyond traditional B2B markets, digitally enabled value propositions will be a precondition to seize new opportunities offered by healthcare consumerization and the new B2C play," said Federico Mayr, research analyst, IDC Health Insights.

| Press Release

Nov-22, IDC TechBrief: Comprehensive Risk Stratification Technology for Value-Based Healthcare

Authors:

• Jennifer Eaton

This IDC TechBrief provides IT and business executives with an executive snapshot on comprehensive risk stratification technology for value-based healthcare, with specific analysis of benefits, risks, adoption rates, success factors, select products, metrics, and investment requirements. Figures 1–7 should be used in business proposals, marketing, use cases, and IT strategy and planning documents.

"To be successful in a value-based healthcare model, providers must have timely, relevant, and accurate data as a foundation for any successful multidimensional improvement program," said Jennifer Eaton, research director, IDC Health Insights. "Never in the history of healthcare has this volume of data been accessible. Now is the time to optimize our tools, create new insights that lead to new efficiencies, and create the quality healthcare standard we all deserve."

| Press Release

Nov-22, IDC FutureScape Webcast: Worldwide Healthcare Industry 2023 Predictions

Authors:

• Mutaz Shegewi

This IDC Web Conference discusses the key predictions that will impact the healthcare industry worldwide over the next five years. Senior and executive-level business, clinical, and IT leaders of healthcare provider and payer organizations will come away from this discussion with actionable insights and analysis for future healthcare industry scenarios. Furthermore, the discussion offers recommendations and guidance for managing the implications these predictions harbor for current and future IT investment priorities and implementation strategies.

To learn more about IDC FutureScape 2023, go to www.idc.com/events/FutureScape.

| Press Release

Nov-22, State of the Market: Health and Life Sciences — Inflation Impact on IT Spending and the Cloud

Authors:

• Lynne Dunbrack
• Jennifer Eaton
• Nino Giguashvili
• Nimita Limaye
• Federico Mayr
• Silvia Piai
• Jeff Rivkin
• Mutaz Shegewi
• Michael Townsend
• Manoj Vallikkat

This IDC Tech Buyer Presentation delves deeper into the impact of inflation on healthcare and life science organizations and includes a discussion of the looming recession. Our analysis also offers IDC's outlook on IT spending and global economics sentiments gleaned from IDC's Future of Enterprise Resiliency and Spending (FERS) Survey.

Analysts across IDC Insights evaluated the impact of eight inflation triggers on their respective industries: supply chain constraints, localized labor shortages, raw materials and component costs, salary increases, tariffs and fiscal policy, energy costs, interest rates, and business margins.

"Inflation is leading health and life sciences organizations to prioritize investments in technologies such as cloud, AI/ML, automation, and advanced analytics, which reduce costs; improve efficiency, productivity, and decision making; and address labor shortages and supply chain constraints." — Lynne A. Dunbrack, group vice president, IDC Health Insights

| Press Release

Nov-22, Smart Cities Asia/Pacific Awards Report Series: Public Health and Social Services

Authors:

• Manoj Vallikkat
• Jezamin Abdul Razak
• Ravikant Sharma

This IDC report covers public health and social services initiatives and deployments across Asia/ Pacific, as part of Smart City—related projects. Urban public health is becoming more relevant at the onset of the pandemic. According to the United Nations, 68% of the world population is projected to live in urban areas by 2050 and this data emphasizes the need to prioritize the public health management by city/state governments.

"Various city/state and province/county authorities in Asia/Pacific are focusing on smart hospitals and innovative applications along with community inclusiveness. Together with tech adoption in care delivery, there must be efforts to make primary care centers smart or uplift the existing ones. Although digital health platforms help immensely in reaching redefined care approach to community level, even in remote areas, to ensure optimum inclusiveness and social impact, the approach needs to be a combination of both digital and physical," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Healthcare Insights.

| Press Release

Oct-22, Driving Sustainability in European Life Sciences

Authors:

• Nino Giguashvili

This IDC Survey Spotlight analyzes the impact of new global sustainability standards on the business agendas and technology investment priorities of European life sciences organizations.

The analysis is based on the life sciences sample of IDC's European Healthcare and Life Sciences Insights Survey, 2022. The sample analyzed in this study covers pharmaceutical organizations, medical device manufacturers, and clinical research organizations across 14 European countries.